| Saji Eapen, MD | |
|
1415 Old Weisgarber Rd, Suite 200, Knoxville, TN 37909-1327 | |
| (865) 934-5800 | |
| (865) 934-5801 |
| Full Name | Saji Eapen |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 33 Years |
| Location | 1415 Old Weisgarber Rd, Knoxville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003804204 | NPI | - | NPPES |
| 2101404 | Other | UNITED HEALTHCARE | |
| 010081424 | Medicaid | VA | |
| 683237 | Other | NCPPO | |
| 7013613 | Other | AETNA PPO | |
| 282529 | Other | AMERIGROUP | |
| 61960002 | Other | BCBS CAREFIRST | |
| 3128998 | Other | MAMSI OPT CHOICE | |
| 010081416 | Medicaid | VA | |
| 3607654 | Other | AETNA HMO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD41548 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fort Sanders Regional Medical Center | Knoxville, TN | Hospital |
| Newport Medical Center | Newport, TN | Hospital |
| Physicians Regional Medical Center | Powell, TN | Hospital |
| Lafollette Medical Center | La follette, TN | Hospital |
| Morristown Hamblen Hospital Association | Morristown, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tennessee Cancer Specialists Pllc | 1658358171 | 48 |
News Archive
Researchers at Georgetown Lombard Comprehensive Cancer Center have been able to show, in mice, how just a little adjustment in the expression of two common genes can promote the kind of cellular changes that led to breast cancer. They say these tweaks likely mimic natural variation women have in expression of the two genes.
Mr. Peter Goodhand, President of The Ontario Institute for Cancer Research (OICR), today announced a new collaborative research study in partnership with Thermo Fisher Scientific and Queen's University to help bring more targeted diagnosis and treatment to breast cancer patients in the future.
Millions of adults are exposed to traumatic events each year. Shortly after exposure many experience symptoms of posttraumatic stress disorder (PTSD) such as flashbacks, emotional numbing and difficulty sleeping.
Proteon Therapeutics, Inc., has initiated a Phase 1/2 human clinical study of its lead product, PRT-201, in end-stage renal disease (ESRD) patients undergoing surgery for arteriovenous graft (AVG) creation. The AVG study represents Proteon's second human clinical study in hemodialysis patients, previously announcing the initiation of a Phase 1/2 study of PRT-201 in ESRD patients undergoing surgery for arteriovenous fistula (AVF) creation earlier this year.
In the spring of 1835, Charles Darwin was bitten in Argentina by a "great wingless black bug," he wrote in his diary. "It is most disgusting to feel soft wingless insects, about an inch long, crawling over one's body," Darwin wrote, "before sucking they are quite thin, but afterwards round & bloated with blood."
› Verified 7 days ago
| Entity Name | Tennessee Cancer Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841228871 PECOS PAC ID: 1658358171 Enrollment ID: O20040702000160 |
News Archive
Researchers at Georgetown Lombard Comprehensive Cancer Center have been able to show, in mice, how just a little adjustment in the expression of two common genes can promote the kind of cellular changes that led to breast cancer. They say these tweaks likely mimic natural variation women have in expression of the two genes.
Mr. Peter Goodhand, President of The Ontario Institute for Cancer Research (OICR), today announced a new collaborative research study in partnership with Thermo Fisher Scientific and Queen's University to help bring more targeted diagnosis and treatment to breast cancer patients in the future.
Millions of adults are exposed to traumatic events each year. Shortly after exposure many experience symptoms of posttraumatic stress disorder (PTSD) such as flashbacks, emotional numbing and difficulty sleeping.
Proteon Therapeutics, Inc., has initiated a Phase 1/2 human clinical study of its lead product, PRT-201, in end-stage renal disease (ESRD) patients undergoing surgery for arteriovenous graft (AVG) creation. The AVG study represents Proteon's second human clinical study in hemodialysis patients, previously announcing the initiation of a Phase 1/2 study of PRT-201 in ESRD patients undergoing surgery for arteriovenous fistula (AVF) creation earlier this year.
In the spring of 1835, Charles Darwin was bitten in Argentina by a "great wingless black bug," he wrote in his diary. "It is most disgusting to feel soft wingless insects, about an inch long, crawling over one's body," Darwin wrote, "before sucking they are quite thin, but afterwards round & bloated with blood."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Saji Eapen, MD 900 E Hill Ave, Suite 230, Knoxville, TN 37915-2566 Ph: (865) 862-0998 | Saji Eapen, MD 1415 Old Weisgarber Rd, Suite 200, Knoxville, TN 37909-1327 Ph: (865) 934-5800 |
News Archive
Researchers at Georgetown Lombard Comprehensive Cancer Center have been able to show, in mice, how just a little adjustment in the expression of two common genes can promote the kind of cellular changes that led to breast cancer. They say these tweaks likely mimic natural variation women have in expression of the two genes.
Mr. Peter Goodhand, President of The Ontario Institute for Cancer Research (OICR), today announced a new collaborative research study in partnership with Thermo Fisher Scientific and Queen's University to help bring more targeted diagnosis and treatment to breast cancer patients in the future.
Millions of adults are exposed to traumatic events each year. Shortly after exposure many experience symptoms of posttraumatic stress disorder (PTSD) such as flashbacks, emotional numbing and difficulty sleeping.
Proteon Therapeutics, Inc., has initiated a Phase 1/2 human clinical study of its lead product, PRT-201, in end-stage renal disease (ESRD) patients undergoing surgery for arteriovenous graft (AVG) creation. The AVG study represents Proteon's second human clinical study in hemodialysis patients, previously announcing the initiation of a Phase 1/2 study of PRT-201 in ESRD patients undergoing surgery for arteriovenous fistula (AVF) creation earlier this year.
In the spring of 1835, Charles Darwin was bitten in Argentina by a "great wingless black bug," he wrote in his diary. "It is most disgusting to feel soft wingless insects, about an inch long, crawling over one's body," Darwin wrote, "before sucking they are quite thin, but afterwards round & bloated with blood."
› Verified 7 days ago
Corey Cudzilo, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2240 Sutherland Ave, Suite 103, Knoxville, TN 37919 Phone: 865-588-8831 Fax: 865-588-8841 | |
Dr. Joshua Weber Todd, M.D. Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 1819 W Clinch Ave, Suite 108, Knoxville, TN 37916 Phone: 865-546-5111 Fax: 865-541-4018 | |
Rasmi Ajit, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9330 Park West Blvd Ste 402, Knoxville, TN 37923 Phone: 865-690-3003 Fax: 865-374-2143 | |
Dr. Spencer Pugh, M.D. Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 1924 Alcoa Hwy, Department Of Medicine U-114 Gsm, Utmck, Knoxville, TN 37920 Phone: 865-305-9340 Fax: 865-305-9144 | |
Jeffrey W Robinson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6600 Nightingale Ln, Knoxville, TN 37909 Phone: 865-632-5885 | |
Dr. Mark D Anderson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1928 Alcoa Hwy, B100, Knoxville, TN 37920 Phone: 865-544-6570 Fax: 865-544-6576 |